Pure Global AI
NCT06106919Not yet recruiting

Ovarian Blockade During Fertility Preservation in Patients With Endometriosis

PFENDO : Ovarian Blockade During Fertility Preservation in Patients With Endometriosis: a Retrospective Non-inferiority Comparative Study
Centre Hospitalier Universitaire de NīmesClinicalTrials.govother
Verified
Study focus
Disease/Condition
Endometriosis
Drug/Device/Intervention
surveys (Fertiqol et SF36)
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire de Nīmes
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Dec 31, 2025
Enrollment
300 participants
Primary outcome

Number of mature oocytes collected by ovarian puncture

Summary

The aim of the study is to demonstrate the non-inferiority of dienogest on the number of
 mature oocytes collected compared with conventional ovarian stimulation protocols (using a
 GnRH agonist or antagonist), in patients with endometriosis in a fertility preservation
 context.

ICD-10 classifications
EndometriosisOther endometriosisEndometriosis, unspecifiedEndometriosis of uterusEndometriosis of ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06106919
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06106919 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Nīmes and is currently Not yet recruiting. The study focuses on Endometriosis. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.